Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Elicio Therapeutics, Inc. See All Filings	D	2024-03-28 18:15:20 UTC
Amount To Be Raised $6,000,000 Associated Brokers / Dealers N/A CIK Number 0001601485 Filed Document 0001601485-24-000017 Exclusions or Exemptions 506b Accepted Date 2024-03-28 18:15:20 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Elicio Therapeutics, Inc. See All Filings	D	2024-01-05 16:05:31 UTC
Amount To Be Raised $7,047,530 Associated Brokers / Dealers N/A CIK Number 0001601485 Filed Document 0001140361-24-001004 Exclusions or Exemptions 506b Accepted Date 2024-01-05 16:05:31 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Angion Biomedica Corp. See All Filings	D	2020-06-23 16:19:13 UTC
Amount To Be Raised $40,000,000 Associated Brokers / Dealers GP Nurmenkari Inc. and T.R. Winston & Company, LLC CIK Number 0001601485 Filed Document 0001601485-20-000004 Exclusions or Exemptions 506b Accepted Date 2020-06-23 16:19:13 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Angion Biomedica Corp. See All Filings	D	2020-01-27 12:17:58 UTC
Amount To Be Raised $12,000,000 Associated Brokers / Dealers GP Nurmenkari Inc. and T.R. Winston & Company, LLC CIK Number 0001601485 Filed Document 0001601485-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-01-27 12:17:58 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Angion Biomedica Corp. See All Filings	D	2020-01-13 14:51:40 UTC
Amount To Be Raised $12,000,000 Associated Brokers / Dealers GP Nurmenkari Inc. and T.R. Winston & Company, LLC CIK Number 0001601485 Filed Document 0001601485-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-01-13 14:51:40 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Debt
Angion Biomedica Corp. See All Filings	D	2018-07-17 16:14:41 UTC
Amount To Be Raised $35,000,000 Associated Brokers / Dealers GP Nurmenkari Inc., H.C. Wainright & Co., LLC, and T.R. Winston & Company, LLC CIK Number 0001601485 Filed Document 0001601485-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-07-17 16:14:41 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Angion Biomedica Corp. See All Filings	D	2018-07-17 16:12:39 UTC
Amount To Be Raised $5,438,891 Associated Brokers / Dealers T.R. Winston & Company, LLC CIK Number 0001601485 Filed Document 0001601485-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-07-17 16:12:39 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Angion Biomedica Corp. See All Filings	D	2015-02-20 00:00:00 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers T.R. Winston & Company, LLC CIK Number 0001601485 Filed Document 0001571049-15-001301 Exclusions or Exemptions 506b Accepted Date 2015-02-20 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $$1,000,001 - $5,000,000 Type of Security Equity